Albumin microspheres
Latest Information Update: 16 Sep 1999
Price :
$50 *
At a glance
- Originator Interactive Medical Technologies
- Class Contrast media
- Mechanism of Action Ultrasonography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Sep 1999 No Development Reported for Undefined indication (diagnosis) in USA (Unknown route)
- 09 Apr 1997 Preclinical development for Undefined indication (diagnosis) in USA (Unknown route)